Manila Times Business
Liminatus Pharma Enters Into Warrant Exercise Transaction for $1.9 Million in Gross Proceeds
FULLERTON, Calif., June 03, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus” or the "Company”) today announced that it has entered into a warrant exercise agreement with existing accredited investors to exercise certain outstanding warrants to purchase an aggregate of 10,344,000 shares of common stock of the Company (the "Existing Warrants”). In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holders were issued new unregister
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
SpaceX stock soars in debut and makes Elon Musk the first trillionaire
Just now
The U.S. Government Just Took a 10% Stake in a Mining Company. Why and Who's Next?
Just now
HorseWood Claims Evaluated: The Horse Gelatin Trick for Natural Male Enhancement Support
Just now
Riding the Momentum of APEC's China Year: Telling China's Story Visits Hanyang University, Engages Korean Youth on the Future of Asia-Pacific Cooperation
Just now